Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
Xiujing He, Xiaowei Liu, Fengli Zuo, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 187-200
Open Access | Times Cited: 149
Tumor immune evasion through loss of MHC class-I antigen presentation
Gülce Sarı, Kenneth L. Rock
Current Opinion in Immunology (2023) Vol. 83, pp. 102329-102329
Open Access | Times Cited: 27
Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells
Jinhuan Xian, Leilei Gao, Zhenyang Ren, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1537-1537
Open Access | Times Cited: 3
Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy
Jialin Feng, Bo Liang, Wenjie Zheng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 7
Open Access | Times Cited: 2
Programmed cell death‐1 blockade therapy in melanoma: Resistance mechanisms and combination strategies
Yixin Zou, Tomonori Yaguchi
Experimental Dermatology (2023) Vol. 32, Iss. 3, pp. 264-275
Open Access | Times Cited: 6
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics
Jimena Álvarez Freile, Yuzhu Qi, Lisa Jacob, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune “cold” tumors
Guixiu Xiao, Yujie Zhao, Xueyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Deciphering MOSPD1’s impact on breast cancer progression and therapeutic response
Yiling Jiang, Xiaojun Liu, Sixuan Wu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
Gabriele Romano, Francesca Paradiso, Peng Li, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 5, pp. 558-569
Open Access | Times Cited: 2
Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers
Lanni Song, Yixin Yang, Xuechen Tian
Cancer Drug Resistance (2024)
Open Access
Platycodin D reduces PD‐L1 levels by inhibiting LXR‐β activity and combines with nintedanib to enhance the tumor‐killing effect of T cells
Jin Lei, Xue‐Wei Cao, Pengfei Li, et al.
FEBS Letters (2024)
Closed Access
Activation of non-classical Wnt signaling pathway effectively enhances HLA-A presentation in acute myeloid leukemia
YuHan Ma, Jun-shuai Yue, Ling Gao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1
Е. С. Герштейн, Anastasia Mochalova, Е. А. Короткова, et al.
Bulletin of Experimental Biology and Medicine (2023) Vol. 175, Iss. 4, pp. 481-486
Closed Access
Page 1

Scroll to top